Disclosures for "Financial and Mental Health Burden on Caregivers of Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States"
-
Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
-
Ms. Rebeira has received personal compensation for serving as an employee of Alexion.
-
Dr. Reguant has received personal compensation for serving as an employee of Alexion.
-
Mr. Loreto has nothing to disclose.
-
Ms. Sullivan has received personal compensation for serving as an employee of EveryLife Foundation for Rare Diseases. An immediate family member of Ms. Sullivan has received personal compensation for serving as an employee of Takeda. Ms. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving as a Policy Advisor with COPD Foundation.
-
Mrs. Crevier has received personal compensation for serving as an employee of Avalere Health.
-
Miss Olsenolsen has nothing to disclose.
-
Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Osborne has received publishing royalties from a publication relating to health care.